Head-to-head dispatch
Peter MD vs Sesame Care
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
Desk Score
An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
Sesame Care takes this head-to-head with the higher Desk Score, 87/100 (B+) against 80/100 (B−) for Peter MD. Peter MD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Peter MD
80/100
B−
Sesame Care
87/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Peter MD | Sesame Care |
|---|---|---|
| Semaglutide | $149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) | From $149/mo (brand Wegovy pill) |
| Tirzepatide | $249/mo (60mg, billed quarterly; $149 first month) | Brand Zepbound (price varies) |
| Coverage | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) | Nationwide marketplace |
| Brand-name | Compounded only | Yes |
| Oral option | Injectable only | Yes |
| Best for | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. | Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program. |
| Desk Score | 80/100B− | 87/100B+ |
The verdict
Desk pick — Sesame CareSesame Care takes this head-to-head with the higher Desk Score, 87/100 (B+) against 80/100 (B−) for Peter MD. Peter MD still holds its ground where its strengths line up with yours.
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) sema · $249/mo (60mg, billed quarterly; $149 first month) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Choose Sesame Care if…
Shoppers who want genuine FDA-approved brand-name GLP-1s and the ability to pick their own provider and see the price up front, rather than one fixed compounded program.
From $149/mo (brand Wegovy pill) sema · Brand Zepbound (price varies) tirz · Nationwide marketplace
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Peter MD · Sesame Care.
Also on the board
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Peter MD vs CoreAge Rx
- Sesame Care vs Vaylen
- Peter MD vs Strut Health
- Sesame Care vs Ondra Health
- Peter MD vs Invigor Medical
- Sesame Care vs Vytora Health
Or see the full comparison hub and the complete board.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.